Agents and strategies in development for improved management of herpes simplex virus infection and disease

By Kleymann Gerald  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 2, 2005-02 ,pp. : 135-161

Informa Healthcare

Access to resources Recommend Favorite

Oncotarget Strategies For Herpes Simplex Virus-1

By  

Current Gene Therapy, Vol. 16, Iss. 2, 2016-04 ,pp. : 130-143

Bentham Science Publishers

Access to resources Recommend Favorite

A Risk-Benefit Evaluation of Aciclovir for the Treatment and Prophylaxis of Herpes Simplex Virus Infections

By Leflore S.   Anderson P.L.   Fletcher C.V.  

Drug Safety, Vol. 23, Iss. 2, 2000-08 ,pp. : 131-142

Adis International

Access to resources Recommend Favorite

Herpes Simplex Virus Infections and Alzheimer's Disease: Implications for Drug Treatment and Immunotherapy

By Leissring M.A.   Sugarman M.C.   LaFerla F.M.  

Drugs & Aging, Vol. 13, Iss. 3, 1998-09 ,pp. : 193-198

Adis International

Access to resources Recommend Favorite

Current Treatments of Muco-Cutaneous Herpes Simplex Virus Infections

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 1, Iss. 1, 2002-01 ,pp. : 83-98

Bentham Science Publishers

Access to resources Recommend Favorite